Home
|
About
|
Quick Start
|
FAQ
Beta Version 0.1
DHARA is an online index of articles on Ayurveda published in research journals worldwide.
Users Online:
1058
Unfiltered
Classified Search
Enter Keyword Below :
Advanced
Complementary Therapies in Medicine
2022
August
;
67
:102824
[Epub ahead of Print]
A randomized, controlled, blinded, parallel group, clinical trial to study the role of Ayurcov (AyurCoro3), one day regimen as an adjuvant therapy for COVID-19 disease management, at dedicated Covid Hospital (DCH) in India
Ajay Prabhakar Sankhe (1)
,
Ajay Prabhakar Sankhe (1)
,
Nanasaheb Somnath Memane (2)
,
Nanasaheb Somnath Memane (2)
,
Vijaykumar P Gawali (3)
,
Vijaykumar P Gawali (3)
,
Sonal Nanasaheb Memane (4)
,
Sonal Nanasaheb Memane (4)
,
Ganesh Ramakrishnan (5)
,
Ganesh Ramakrishnan (5)
,
Tapanendu Kundu (6)
,
Tapanendu Kundu (6)
,
Mayur Nimba Bagul (7)
,
Mayur Nimba Bagul (7)
,
Ashotosh Kumar (8)
,
Ashotosh Kumar (8)
,
Vikram Bansal (9)
,
Vikram Bansal (9)
,
Rashmi Tiwari (10)
,
Rashmi Tiwari (10)
1. Bhaktivedanta Hospital and Research Institute, India. Electronic address: apsankhe@bhaktivedantahospital.com. 2. Bhaktivedanta Hospital and Research Institute, India. Electronic address: drnanasaheb.m@bhaktivedantahospital.com. 3. Bhaktivedanta Hospital and Research Institute, India. Electronic address: drvijaykumar.g@bhaktivedantahospital.com. 4. Bhaktivedanta Hospital and Research Institute, India. Electronic address: drsonal.memane@bhaktivedantahospital.com. 5. Indian Institute of Technology, Bombay, India. Electronic address: ganesh@cse.iitb.ac.in. 6. Indian Institute of Technology, Bombay, India. Electronic address: tkundu@phy.iitb.ac.in. 7. Bhaktivedanta Hospital and Research Institute, India. Electronic address: mayur.bagul@bhaktivedantahospital.com 8. Indian Institute of Technology, Bombay, India. Electronic address: ashutoshk@iitb.ac.in. 9. Indian Institute of Technology, Bombay, India. Electronic address: vikram.bansal@tekolutions.com. 10. Indian Institute of Technology, Bombay, India. Electronic address: rashmistats@gmail.com.
Abstract
Introduction: Limited treatment options exist for COVID-19 infections; thus, attempts from complementary and alternative systems (CAM) of medicine are being explored as possible therapeutic options. Ayurcov is a formulation made of ingredients mentioned in Ayurveda. These constituents have proven antiviral, detoxifying, immune-modulating, and bio-enhancing properties. The present study was carried out to evaluate the therapeutic effect and safety of Ayurcov in patients with various severity states of COVID-19 infections. Methods: A randomized, single blinded, controlled trial was carried out in adults diagnosed with mild-to-moderate, and severe COVID-19 infections confirmed by real time reverse transcriptase polymerase chain reaction (rRTPCR) test. The interventional group received three doses of 'Ayurcov'. It is constituted of Haridra Churna (Curcuma longa), Go ark (Bos Indicus Distilled Urine), Sphatika (Alum), Sita (Rock Candy), Godugdham (Bos Indicus Milk) milk, Goghritam (Bos Indicus ghee) on Day 1, as an adjuvant to the standard of care, and the control group received only the standard of care. Key outcomes included: proportion of patients and time taken for symptom resolution, reduction in the rRT-PCR Ct values, safety, and functional status until 42 days after discharge. Results: Ninety patients with mild-to-moderate and 30 patients with severe COVID-19 disease were recruited. It was observed that significantly more proportions of patients receiving Ayurcov had symptom relief much earlier than control group. Additionally, the interventional group showed significantly lower rRT-PCR Ct values. However, a shorter time of resolution of symptoms was observed with the interventional group in the mild to moderate category but not with those having severe symptoms. Similarly, a significantly better functional status was observed with interventional group on days 7 and 28 after discharge. Ayurcov was not observed with higher risks of any adverse/serious adverse events. Conclusions: Ayurcov as adjuvant with standard of care was associated with significantly earlier resolution of COVID-19 related symptoms than standard of care alone. Keywords: Ayurcov; Ayurveda; CAM; COVID-19; Complementary and alternative medicine.
DHARA ID:
D058306
Pubmed ID:
35341943
Link To Full Paper
Replica Louis vuitton Belts
Replica Louis vuitton Handbags
Replica Louis vuitton Backpack
Replica Louis vuitton Capucines Bags
Imitazioni Louis vuitton Borse
Imitazioni Louis vuitton Cinture
Imitazioni Louis vuitton Occhiali
Replica Louis vuitton Geldb?rsen
Replica Louis vuitton Gürtel
Replica Louis vuitton Schmuck
Replica Louis vuitton Schal
Imitation Louis vuitton Bijoux
Imitation Louis vuitton Ceinture
Imitation Louis vuitton Chaussures
Imitation Louis vuitton Foulard
namaak Louis vuitton Gordels
namaak Louis vuitton Handtassen
namaak Louis vuitton Portemonnees
namaak Louis vuitton Schoenen
Replica Louis vuitton Bolsos
Replica Louis vuitton Billeteras
Replica Louis vuitton Cinturones
Dior Replica
Hermès Replica
Yves Saint Laurent Replica
Goyard Replica
Imitation Louis Vuitton
Imitation Hermès
Imitation Dior
Imitation Yves Saint Laurent
Imitazioni Bottega Veneta Borse
Imitazioni Delvaux Borse
Imitazioni Goyard Borse
Replica Taschen
Replica Louis Vuitton
Replica Hermès
Replica Dior
Replica Bottega Veneta tassen
Replica Chloé tassen
Replica Delvaux tassen
Replica Goyard tassen
imitacion Louis Vuitton
imitacion Louis Vuitton
imitacion Hermès
imitacion Dior
Replica Miu Miu
Replica Prada
Replica Yves Saint Laurent
Replica Chanel
Replica Gucci
Replica Hermès
Replica Miu Miu
Réplique Chanel
Réplique Hermès
Réplique Miu Miu
Imitazioni Chanel
Imitazioni Hermès
Imitazioni Miu Miu
imitacion Bolso Yves Saint Laurent
imitacion Hermes
imitacion Chanel
imitacion Gucci
Gucci Replica
Hermes Replica
Copyright
|
Disclaimer
|
Feedback
|
Updates
|
Contact
Developed and maintained by AVP Research Foundation (Formerly AVT Institute for Advanced Research), 136/137, Trichy Road, Ramanathapuram, Coimbatore - 641045, Tamil Nadu, India
Funded by Central Council for Research in Ayurvedic Sciences, Dept. of AYUSH, Ministry of Health and Family Welfare, Government of India, New Delhi